Cat. No. 3496
Chemical Name: (2R)-1-[[2-[(Aminocarbonyl)amino]-4
Biological ActivityPotent, selective non-peptide CCR1 antagonist (Ki = 1 nM for human CCR1). Exhibits 250-fold selectivity for CCR1 over CCR2, CCR5 and CXCR4. Inhibits MIP-α/CCL3-induced intracellular Ca2+ mobilization. Orally active; effectively reduces disease severity in a rat model of multiple sclerosis. Decreases renal fibrosis in a mouse model of obstructive nephropathy.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Furuichi et al (2008) Chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injury. J.Immunol. 181 8670. PMID: 19050287.
Anders (2002) A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J.Clin.Invest. 109 (2) 251. PMID: 11805137.
Liang (2000) Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1. J.Biol.Chem. 275 (25) 19000. PMID: 10748002.
If you know of a relevant reference for BX 471 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses BX 471 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: BX 471, supplier, selective, chemokine, receptor, antagonists, CCR1, BX471, multiple, sclerosis, renal, fibrosis, leukocyte, recruitment, Rantes, Tocris Bioscience, Chemokine CC Receptor Antagonist products